AbbVie, Inc.(NYSE : ABBV)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||1.17%||179.05||0.7%||$1368.39m|
|BMY||Bristol-Myers Squibb Co.||0.82%||76.82||1.0%||$1207.17m|
|MRK||Merck & Co., Inc.||0.37%||93.90||0.7%||$1143.92m|
|LLY||Eli Lilly & Co.||0.83%||301.33||1.1%||$899.61m|
|BHVN||Biohaven Pharmaceutical Holding Co. Ltd.||0.47%||142.70||0.0%||$460.66m|
|HZNP||Horizon Therapeutics Plc||-2.24%||88.33||5.4%||$195.92m|
|NVO||Novo Nordisk A/S||0.08%||107.84||0.1%||$190.89m|
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.